Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
Go back to Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance| Edwards Lifesciences (NYSE: EW) | Delayed: 85.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.76 | 52 Week High | $166.87 | |||
| Open | $85.76 | 52 Week Low | $72.20 | |||
| Day High | $85.76 | P/E | 24.93 | |||
| Day Low | $85.76 | EPS | $3.44 | |||
| Volume | 10 | |||||
